BUSINESSCipla Bags Exclusive US Rights for Keytruda BiosimilarTabassum ChaudharySeptember 4, 2026September 4, 2026 September 4, 2026September 4, 2026 Cipla InvaGen signed an exclusive deal with Qilu Pharmaceutical to license QL2107, a Keytruda biosimilar, in the US. For those wondering what a biosimilar actually...